CHCT stock is currently trading at $18.90, below its recent price target of $23 set by Truist Securities, which maintained a "Strong Buy" rating. The stock's valuation metrics, such as a forward P/E of 8.28 and a P/B ratio of 1.08, indicate it is undervalued compared to peers, making it attractive for value investors. However, recent high options activity at the $17.50 strike put suggests bearish sentiment in the short term.